Johnson & Johnson (J&J) will provide the list price of its prescription drugs in television advertisements starting in late March. The company will be the first manufacturer to take such a step, according to The New York Times.

As the rising drug price issue has taken hold of the healthcare debate in the U.S., Democrats in Congress have introduced a bill that would allow Medicare to negotiate drug prices. 

The price for a drug that treats Lambert-Eaton Myasthenic Syndrome (LEMS), a rare neuromuscular disorder that impacts strength and impairs walking, went from cost-free to the price of a house—$375,000 to be exact. 

Approximately two-thirds of U.S.-based hospitals and acute-care facility leaders believe diagnosis-related group (DRG) optimization is still a problem that needs to be solved in revenue cycle management, according to a recent survey conducted by BESLER and HIMSS Media.

Families with subsidized health insurance through the Affordable Care Act (ACA) may experience indirect financial benefits that go beyond health costs—to housing, according to new research published in the Journal of Public Economics. 

The growth in hospital prices is driving up healthcare costs for private insurance more than the rise in physician prices, according to a recent study in Health Affairs.

After signing a letter of intent to explore a merger in October 2018, Baylor Scott & White Health and Memorial Hermann Health System have dissolved the plan.

Since CMS proposed expanding supplemental benefits for Medicare Advantage for the 2020 plan year, several industry groups have voiced their support, seeing opportunities to improve care for individuals with chronic illnesses and lower costs.